Abstract

In this study, supercritical fluid-assisted spray-drying (SA-SD) was applied to achieve the micronization of fenofibrate particles possessing surface-active additives, such as d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), sucrose mono palmitate (Sucroester 15), and polyoxyethylene 52 stearate (Myrj 52), to improve the pharmacokinetic and pharmacodynamic properties of fenofibrate. For comparison, the same formulation was prepared using a spray-drying (SD) process, and then both methods were compared. The SA-SD process resulted in a significantly smaller mean particle size (approximately 2 μm) compared to that of unprocessed fenofibrate (approximately 20 μm) and SD-processed particles (approximately 40 μm). There was no significant difference in the effect on the particle size reduction among the selected surface-active additives. The microcomposite particles prepared with surface-active additives using SA-SD exhibited remarkable enhancement in their dissolution rate due to the synergistic effect of comparably moderate wettability improvement and significant particle size reduction. In contrast, the SD samples with the surface-active additives exhibited a decrease in dissolution rate compared to that of the unprocessed fenofibrate due to the absence of particle size reduction, although wettability was greatly improved. The results of zeta potential and XPS analyses indicated that the surface-active additive coverage on the surface layer of the SD-processed particles with a better wettability was higher than that of the SA-SD-processed composite particles. Additionally, after rapid depletion of hydrophilic additives that were excessively distributed on the surfaces of SD-processed particles, the creation of a surface layer rich in poorly water-soluble fenofibrate resulted in a decrease in the dissolution rate. In contrast, the surface-active molecules were dispersed homogeneously throughout the particle matrix in the SA-SD-processed microparticles. Furthermore, improved pharmacokinetic and pharmacodynamic characteristics were observed for the SA-SD-processed fenofibrate microparticles compared to those for the SD-processed fenofibrate particles. Therefore, the SA-SD process incorporating surface-active additives can efficiently micronize poorly water-soluble drugs and optimize their physicochemical and biopharmaceutical characteristics.

Highlights

  • The experimental runs with the independent variables, including the drug/additive solution concentration, CO2 injection rate, and additive content based on the BBD and the pharmaceutical evaluation results of microparticles obtained through each run, are presented in the Supplementary Material

  • It was demonstrated that the BBD is suitable for the exploration of quadratic response surfaces and the construction of a second-order polynomial model, helping to understand the effect of various independent formulation or process variables on the particle formation via the supercritical fluid-assisted spray-drying (SA-SD) process using a small number of experimental runs

  • It was demonstrated that the particle size reduction and the improvement of the wetting property enabled by SA-SD processing with surface-active additives can lead to improved in vitro and in vivo performances in regard to the dissolution rate, the oral bioavailability, and, the lipid-lowering effect of fenofibrate

Read more

Summary

Introduction

Major efforts have been made in the pharmaceutical industry to improve the bioavailability and/or the onset of action of these drugs by focusing on increasing the dissolution rate of poorly water-soluble drugs via the reduction of particle size (i.e., micronization) through the use of hydrophilic surface-active materials [1,2,3,4,5,6,7,8] In response to these needs, microparticle preparation technologies using supercritical fluids (SCF), carbon dioxide, have been applied to improve the physicochemical properties of drug particles via fine control of particle precipitation. The effect of the dissolution rate enhancement on the pharmacokinetic and pharmacodynamic performance of fenofibrate was studied in Sprague–Dawley rats

Materials
SA-SD Process
Particle Size Analysis
Zeta Potential Measurement
Contact Angle Measurement
Dissolution Test
In Vivo Studies Using Sprague–Dawley Rats
Results and Discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call